Skip to content

Clinical trials

Recruiting Lung Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Recruiting Country / region: Taiwan Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20172
20191
20214
20226
20237
20244
202514
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital4
Pfizer4
Bristol-Myers Squibb3
Chung Shan Medical University3
Taipei Medical University3
Merck Sharp & Dohme LLC2
Revolution Medicines, Inc.2
Academia Sinica, Taiwan1
Amgen1
Apollomics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms46
Carcinoma, Non-Small-Cell Lung24
Carcinoma6
Neoplasms5
Disease4
Lung Diseases4
Stomach Neoplasms4
Breast Neoplasms3
Bronchial Neoplasms3
Head and Neck Neoplasms3

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.